IT Community Malaysia

Mounjaro 10 mg Pen (tirzepatide) is a prescription medication commonly used to help adults with type 2 diabetes improve blood sugar control when combined with a healthy diet and regular exercise. Manufactured by Eli Lilly and Company, Mounjaro injection works by activating both GIP and GLP-1 receptors, helping the body release insulin more effectively, reduce glucose production, slow stomach emptying, and support appetite control. Many patients also experience significant weight loss while using Mounjaro pre-filled pen under medical supervision. The once-weekly injection is administered using a convenient prefilled pen and can be injected into the abdomen, thigh, or upper arm. Common side effects may include nausea, diarrhea, decreased appetite, vomiting, and stomach discomfort, especially during dose adjustments. Patients should follow their healthcare provider’s instructions regarding dosage and monitoring to achieve the best results and maintain long-term blood sugar management.